Literature DB >> 28496609

Anticoagulation During AF Ablation: The Balance between Thromboembolism and Bleeding.

Jennifer A Mears1, Samuel J Asirvatham1,2.   

Abstract

Radiofrequency ablation for atrial fibrillation is being increasingly used to treat patients with symptomatic arrhythmia. The procedure is complex and associated with significant complications including thromboembolism, stroke, and bleeding. Despite significant advances in catheter design, online cardiac imaging, and greater operator experience, both stroke and major vascular complications continue to be problematic. Increasing the duration and intensity of anticoagulation has been the primary modality used to decrease thromboembolism. However, these measures increase the likelihood and severity of bleeding-related complications. The optimal method of anticoagulation along with the adjunctive use of technology to decrease vascular complications and mechanically prevent cerebral embolization is unknown. In this paper, we review the present methods used by ablationists to decrease the likelihood of thromboembolism during atrial fibrillation. We then describe methods used to decrease bleeding and vascular complications at access sites as well as cardiac perforation. We briefly discuss newer techniques to decrease endovascular complications including epicardial ablation and the use of temporarily implanted vascular protection devices.Finally, we describe the best option or combination of approaches that attempt to balance the risks of thromboembolism and bleeding during AF ablation..

Entities:  

Year:  2009        PMID: 28496609      PMCID: PMC5395039          DOI: 10.4022/jafib.153

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  60 in total

1.  Radiofrequency catheter ablation: different cooled and noncooled electrode systems induce specific lesion geometries and adverse effects profiles.

Authors:  Uwe Dorwarth; Michael Fiek; Thomas Remp; Cristopher Reithmann; Martin Dugas; Gerhard Steinbeck; Ellen Hoffmann
Journal:  Pacing Clin Electrophysiol       Date:  2003-07       Impact factor: 1.976

Review 2.  Epicardial mapping and ablation techniques to control ventricular tachycardia.

Authors:  Eduardo Sosa; Mauricio Scanavacca
Journal:  J Cardiovasc Electrophysiol       Date:  2005-04

3.  How do we get there from here-is it safe and in whose hands?

Authors:  Samuel J Asirvatham; David R Holmes
Journal:  J Cardiovasc Electrophysiol       Date:  2005-06

4.  Silent cerebral thromboembolism with left atrial ablation: a lurking danger.

Authors:  Samuel J Asirvatham; Paul A Friedman
Journal:  J Cardiovasc Electrophysiol       Date:  2006-01

5.  Safety and efficacy of the Perclose suture-mediated closure device after diagnostic and interventional catheterizations in a large consecutive population.

Authors:  Zalman M Kahn; Mukesh Kumar; Gerald Hollander; Robert Frankel
Journal:  Catheter Cardiovasc Interv       Date:  2002-01       Impact factor: 2.692

6.  Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro).

Authors:  J R Chamberlin; A B Lardi; L S McKeever; M H Wang; G Ramadurai; P Grunenwald; W P Towne; E D Grassman; F S Leya; B E Lewis; L H Stein
Journal:  Catheter Cardiovasc Interv       Date:  1999-06       Impact factor: 2.692

7.  Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging.

Authors:  Oussama M Wazni; Antonio Rossillo; Nassir F Marrouche; Eduardo B Saad; David O Martin; Mandeep Bhargava; Dianna Bash; Salwa Beheiry; Mark Wexman; Domenico Potenza; Ennio Pisano; Raffaele Fanelli; Aldo Bonso; Sakis Themistoclakis; Demet Erciyes; Walid I Saliba; Robert A Schweikert; Johannes Brachmann; Antonio Raviele; Andrea Natale
Journal:  J Cardiovasc Electrophysiol       Date:  2005-06

8.  Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography.

Authors:  Jian-Fang Ren; Francis E Marchlinski; David J Callans
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

9.  Failure of fixed dose intravenous heparin to suppress increases in thrombin activity after coronary thrombolysis with streptokinase.

Authors:  M Galvani; D R Abendschein; D Ferrini; F Ottani; F Rusticali; P R Eisenberg
Journal:  J Am Coll Cardiol       Date:  1994-11-15       Impact factor: 24.094

10.  The history of atrial fibrillation: the last 100 years.

Authors:  Eric N Prystowsky
Journal:  J Cardiovasc Electrophysiol       Date:  2008-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.